Keywords: Small Animals, Genetic Diseases, Volumetric
Motivation: Robust translational imaging biomarkers are needed to facilitate the development of disease-modifying treatments for Huntington’s disease (HD), a rare inherited neurodegenerative disease.
Goal(s): To determine the use of structural atrophy determined with MRI as a robust translational biomarker for testing therapeutics in mouse models prior to people with HD.
Approach: In this work, we used semi-automatic delineations and tensor-based morphometry (TBM) of 3D high-resolution anatomical MR images to assess structural anomalies in the knock-in zQ175DN model of HD at different ages.
Results: We detected progressive volumetric decrease in the zQ175DN mouse model, offering a powerful translational biomarker for the assessment of disease-modifying therapies.
Impact: We report the first brain-wide structural study of zQ175DN mice using in vivo MRI. Our work supports structural atrophy as a robust translational biomarker for testing therapeutics in mouse models prior to people with HD.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords